Authors
Loading...
Research reveals three core transcriptional subtypes in high-grade serous ovarian cancer, indicating potential for tailored patient treatments.
Barnes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: